Risk factors for enterococcal urinary tract infections: a multinational, retrospective cohort study.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 19 09 2020
accepted: 21 02 2021
pubmed: 3 3 2021
medline: 27 11 2021
entrez: 2 3 2021
Statut: ppublish

Résumé

Complicated urinary tract infection (cUTI) is a frequent cause of morbidity. In this multinational retrospective cohort study, we aimed to demonstrate risk factors for enterococcal UTI. Univariate and multivariate analyses of risk factors for enterococcal infection were performed. Among 791 hospitalized patients with cUTI, enterococci accounted for approximately 10% of cases (78/791). Risk factors for enterococcal UTI in multivariable analysis were male gender, age range of 55-75 years, catheter-associated UTI, and urinary retention. This information may assist treating physicians in their decision-making on prescribing empiric anti-enterococcus treatment to hospitalized patients presenting with cUTI and thus improve clinical outcomes.

Identifiants

pubmed: 33651207
doi: 10.1007/s10096-021-04207-4
pii: 10.1007/s10096-021-04207-4
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2005-2010

Subventions

Organisme : Innovative Medicines Initiative Joint Undertaking
ID : 115523 | 115620 | 115737 | 777362

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Références

Czaja CA, Scholes D, Hooton TM, Stamm WE (2007) Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis Off Publ Infect Dis Soc Am 45(3):273–280. https://doi.org/10.1086/519268
doi: 10.1086/519268
Giannakopoulos X, Sakkas H, Ragos V et al (2019) Impact of enterococcal urinary tract infections in immunocompromised - neoplastic patients. J BUON 24(5):1768–1775
pubmed: 31786836
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13(5):269–284. https://doi.org/10.1038/nrmicro3432
doi: 10.1038/nrmicro3432 pubmed: 25853778 pmcid: 4457377
Levison ME, Kaye D (2013) Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens. Curr Infect Dis Rep 15(2):109–115. https://doi.org/10.1007/s11908-013-0315-7
doi: 10.1007/s11908-013-0315-7 pubmed: 23378123
Fisher JF, Kavanagh K, Sobel JD, Kauffman CA, Newman CA (2011) Candida urinary tract infection: pathogenesis. Clin Infect Dis Off Publ Infect Dis Soc Am 52(Suppl 6):S437–S451. https://doi.org/10.1093/cid/cir110
doi: 10.1093/cid/cir110
Chen YH, Ko WC, Hsueh PR (2013) Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections. Expert Opin Pharmacother 14(5):587–596. https://doi.org/10.1517/14656566.2013.778827
doi: 10.1517/14656566.2013.778827 pubmed: 23480061
Jacobsen SM, Stickler DJ, Mobley HLT, Shirtliff ME (2008) Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 21(1):26–59. https://doi.org/10.1128/CMR.00019-07
doi: 10.1128/CMR.00019-07 pubmed: 18202436 pmcid: 2223845
Maki DG, Tambyah PA (2001) Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 7(2):342–347. https://doi.org/10.3201/eid0702.010240
doi: 10.3201/eid0702.010240 pubmed: 11294737 pmcid: 2631699
Ramsey AM, Zilberberg MD (2009) Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol 30(2):184–186. https://doi.org/10.1086/593956
doi: 10.1086/593956 pubmed: 19125679
Agudelo Higuita NI, Huycke MM (2014) Enterococcal Disease, Epidemiology, and Implications for Treatment. In: Gilmore MS, Clewell DB, Ike Y, Shankar N, eds. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection. Massachusetts Eye and Ear Infirmary. http://www.ncbi.nlm.nih.gov/books/NBK190429/ . Accessed 28 Dec 2019
Data from the ECDC Surveillance Atlas - Antimicrobial resistance. European Centre for Disease Prevention and Control. https://www.ecdc.europa.eu/en/antimicrobial-resistance/surveillance-and-disease-data/data-ecdc . Accessed 5 June 2020
Noskin GA, Peterson LR, Warren JR (1995) Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 20:296–301. https://doi.org/10.1093/clinids/20.2.296
doi: 10.1093/clinids/20.2.296 pubmed: 7742433
Patterson JE, Sweeney AH, Simms M, Carley N, Mangi R, Sabetta J, Lyons RW (1995) An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine (Baltimore) 74:191–200. https://doi.org/10.1097/00005792-199507000-00003
doi: 10.1097/00005792-199507000-00003
McBride SJ, Upton A, Roberts SA (2010) Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review. Eur J Clin Microbiol Infect Dis 29:107–114. https://doi.org/10.1007/s10096-009-0830-5
doi: 10.1007/s10096-009-0830-5 pubmed: 19916034
Garrison RN, Fry DE, Berberich S, Polk HC (1982) Enterococcal bacteremia: clinical implications and determinants of death. Ann Surg 196:43–47. https://doi.org/10.1097/00000658-198207000-00010
doi: 10.1097/00000658-198207000-00010 pubmed: 6807223 pmcid: 1352495
Gray J, Marsh PJ, Stewart D, Pedler SJ (1994) Enterococcal bacteraemia: a prospective study of 125 episodes. J Hosp Infect 27:179–186. https://doi.org/10.1016/0195-6701(94)90125-2
doi: 10.1016/0195-6701(94)90125-2 pubmed: 7963458
Graninger W, Ragette R (1992) Nosocomial bacteremia due to Enterococcus faecalis without endocarditis. Clin Infect Dis 15:49–57. https://doi.org/10.1093/clinids/15.1.49
doi: 10.1093/clinids/15.1.49 pubmed: 1617073
Eliakim-Raz N, Babitch T, Shaw E et al (2019) Risk factors for treatment failure and mortality among hospitalized patients with complicated urinary tract infection: a multicenter retrospective cohort study (RESCUING Study Group). Clin Infect Dis 68(1):29–36. https://doi.org/10.1093/cid/ciy418
doi: 10.1093/cid/ciy418 pubmed: 29788118
Jombo GT, Emanghe UE, Amefule EN, Damen JG (2011) Urinary tract infections at a Nigerian university hospital: Causes, patterns and antimicrobial susceptibility profile. J Microbiol Antimicrob 3(6):153–159
Mathai D, Jones RN, Pfaller MA (2001) SENTRY Participant Group North America. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 40(3):129–136. https://doi.org/10.1016/s0732-8893(01)00254-1
doi: 10.1016/s0732-8893(01)00254-1 pubmed: 11502382
Bouza E, San Juan R, Muñoz P, Voss A, Kluytmans J (2001) Co-operative group of the european study group on nosocomial infections. A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect 7(10):523–531. https://doi.org/10.1046/j.1198-743x.2001.00326.x
doi: 10.1046/j.1198-743x.2001.00326.x pubmed: 11683792
Bouza E, San Juan R, Muñoz P, Voss A, Kluytmans J (2001) Co-operative group of the european study group on nosocomial infections. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection. Clin Microbiol Infect 7(10):532–542. https://doi.org/10.1046/j.1198-743x.2001.00324.x
doi: 10.1046/j.1198-743x.2001.00324.x pubmed: 11683793
Madrazo M, Esparcia A, Alberola J et al (2020) Predictive factors for Enterococcus faecalis in complicated community-acquired urinary tract infections in older patients. Geriatr Gerontol Int 20(3):183–186. https://doi.org/10.1111/ggi.13856
doi: 10.1111/ggi.13856 pubmed: 31876112
Kajihara T, Nakamura S, Iwanaga N et al (2015) Clinical characteristics and risk factors of enterococcal infections in Nagasaki, Japan: a retrospective study. BMC Infect Dis 15. https://doi.org/10.1186/s12879-015-1175-6
Pinholt M, Ostergaard C, Arpi M et al (2014) Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 20(2):145–151. https://doi.org/10.1111/1469-0691.12236
doi: 10.1111/1469-0691.12236
Billington EO, Phang SH, Gregson DB et al (2014) Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study. Int J Infect Dis IJID Off Publ Int Soc Infect Dis 26:76–82. https://doi.org/10.1016/j.ijid.2014.02.012
doi: 10.1016/j.ijid.2014.02.012
Saia RS, Garcia FM, Cárnio EC (2015) Estradiol protects female rats against sepsis induced by Enterococcus faecalis improving leukocyte bactericidal activity. Steroids. 102:17–26. https://doi.org/10.1016/j.steroids.2015.06.016
doi: 10.1016/j.steroids.2015.06.016 pubmed: 26143494
Cornia PB, Takahashi TA, Lipsky BA (2006) The microbiology of bacteriuria in men: a 5-year study at a Veterans’ Affairs hospital. Diagn Microbiol Infect Dis 56(1):25–30. https://doi.org/10.1016/j.diagmicrobio.2006.03.008
doi: 10.1016/j.diagmicrobio.2006.03.008 pubmed: 16713165
Gomila A, Carratalà J, Eliakim-Raz N et al (2019) Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study. Antimicrob Resist Infect Control 8:198. https://doi.org/10.1186/s13756-019-0656-6
doi: 10.1186/s13756-019-0656-6 pubmed: 31827779 pmcid: 6892205
Zielinski MD, Kuntz MM, Polites SF et al (2015) A prospective analysis of urinary tract infections among elderly trauma patients. J Trauma Acute Care Surg 79(4):638–642. https://doi.org/10.1097/TA.0000000000000796
doi: 10.1097/TA.0000000000000796 pubmed: 26402539 pmcid: 4582427

Auteurs

Adi Turjeman (A)

Department of Medicine E, Beilinson Hospital, Rabin Medical Center, 39 Jabotinsky Road, 49100, Petah-Tikva, Israel. aditur88@gmail.com.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. aditur88@gmail.com.

Tanya Babich (T)

Department of Medicine E, Beilinson Hospital, Rabin Medical Center, 39 Jabotinsky Road, 49100, Petah-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Miquel Pujol (M)

Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Spanish Network for Research in Infectious Diseases (REIPI RD12/0015)), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Jordi Carratalà (J)

Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Spanish Network for Research in Infectious Diseases (REIPI RD12/0015)), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Evelyn Shaw (E)

Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Spanish Network for Research in Infectious Diseases (REIPI RD12/0015)), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Aina Gomila-Grange (A)

Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Spanish Network for Research in Infectious Diseases (REIPI RD12/0015)), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Infectious Diseases, Hospital Universitari Parc Taulí, Barcelona, Spain.

Cuong Vuong (C)

AiCuris Anti-infective Cures GmbH, Wuppertal, Germany.

Ibironke Addy (I)

AiCuris Anti-infective Cures GmbH, Wuppertal, Germany.

Irith Wiegand (I)

AiCuris Anti-infective Cures GmbH, Wuppertal, Germany.

Sally Grier (S)

Department of Infection Sciences, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.

Alasdair MacGowan (A)

Department of Infection Sciences, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.

Christiane Vank (C)

AiCuris Anti-infective Cures GmbH, Wuppertal, Germany.

Nienke Cuperus (N)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

Leo van den Heuvel (L)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

Leonard Leibovici (L)

Department of Medicine E, Beilinson Hospital, Rabin Medical Center, 39 Jabotinsky Road, 49100, Petah-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Noa Eliakim-Raz (N)

Department of Medicine E, Beilinson Hospital, Rabin Medical Center, 39 Jabotinsky Road, 49100, Petah-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH